• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·SYSCHEM.BO
Share

Syschem (India) Limited Stocks

₹ 35.12Last Updated 19.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 19.63M

₹ 35.12
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Syschem India Limited is a company focused on manufacturing active pharmaceutical ingredients (APIs), chemical intermediates, and specialized chemical products. Its offerings include a range of antibiotics like amoxicillin tri hydrate, ampicillin tri hydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, oxacillin, and cephalexin. The firm began operations on December 31, 1993, and its main office is located in Chandigarh, India.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 14:26

From PDF files to drone defense: How Finland's newest billionaire built his business

20.10.2026 13:42

Revolut Experiences an Outage: Customers Report Issues with Payments and the App

20.10.2026 12:47

Shares of the AI startup Elice plummeted 32% after its IPO. Why is this a bad sign for the market?

20.10.2026 11:34

The New Energy Boom: How to Profit from the Growth of the Battery Market

20.10.2026 10:49

Morning Highlights: AI Startup's Stock Plummets After IPO; Anthropic and Nscale Deal

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026